Lantheus appoints Julie Eastland to Board of Directors, effective Sept 3, 2024

Lantheus Holdings, Inc.

Board size increased to ten directors; Eastland is a Class I director and Audit Committee member.
Eastland qualifies as independent under Nasdaq rules; compensation includes $60K/yr cash plus prorated equity grant valued at $266,666.67.
She brings biotech and finance experience, most recently CEO of Harpoon Therapeutics until its acquisition by Merck in March 2024.
No arrangements or family relationships with existing directors or officers; no disclosable transactions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julie Eastland

Director

LNTH · Lantheus Holdings, Inc.

Effective: 2024-09-03
Filed: September 5, 2024, 7:59 PM ET

On September 3, 2024, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Julie Eastland, an experienced biotechnology and financial executive, to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Julie Eastland was appointed as Director at Lantheus Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On September 3, 2024, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Julie Eastland, an experienced biotechnology and financial executive, to the Board.

View on SEC.gov

Lantheus Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-213726

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.